| Josie Lyn Johnson, SLP | |
|
5250 Heritage Pkwy, Fort Wayne, IN 46835-1061 | |
| (260) 209-6279 | |
| Not Available |
| Full Name | Josie Lyn Johnson |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 5250 Heritage Pkwy, Fort Wayne, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003408121 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Provider Name | Anew Therapy & Wellness Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1225792534 PECOS PAC ID: 8123415312 Enrollment ID: O20220418000863 |
News Archive
According to Simon Stevens, Chief Executive of NHS England, the NHS is looking at an epidemic of mental ill health among children and teenagers as an after effect of social media.
The first human case of West Nile virus infection this year has been identified in Manitoba. The individual, a Winnipeg resident in his sixties, is currently in hospital. The individual has been reported to Health Canada as a probable case of West Nile neurological syndrome.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has initiated phase II clinical trials of its T-cell vaccines targeting house dust mite and cat allergies. With the start of these studies, and the ongoing trial of Circassia's ragweed allergy (hay fever) T-cell vaccine, the company now has three clinical development programmes in phase II.
IVF FLORIDA Reproductive Associates today announced their partnership with Springstone Financial LLC to provide patients with improved financing options to fund IVF procedures and certain other fertility treatments. Financing programs are available to IVF FLORIDA and all IntegraMed Fertility Network patients immediately.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 for the treatment of patients with castration resistant prostate cancer (CRPC). TOK-001 is the only compound in development that combines three distinct mechanisms of action for the treatment of CRPC.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Josie Lyn Johnson, SLP 3003 Grandview Dr, Fort Wayne, IN 46804-2821 Ph: (260) 224-7032 | Josie Lyn Johnson, SLP 5250 Heritage Pkwy, Fort Wayne, IN 46835-1061 Ph: (260) 209-6279 |
News Archive
According to Simon Stevens, Chief Executive of NHS England, the NHS is looking at an epidemic of mental ill health among children and teenagers as an after effect of social media.
The first human case of West Nile virus infection this year has been identified in Manitoba. The individual, a Winnipeg resident in his sixties, is currently in hospital. The individual has been reported to Health Canada as a probable case of West Nile neurological syndrome.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has initiated phase II clinical trials of its T-cell vaccines targeting house dust mite and cat allergies. With the start of these studies, and the ongoing trial of Circassia's ragweed allergy (hay fever) T-cell vaccine, the company now has three clinical development programmes in phase II.
IVF FLORIDA Reproductive Associates today announced their partnership with Springstone Financial LLC to provide patients with improved financing options to fund IVF procedures and certain other fertility treatments. Financing programs are available to IVF FLORIDA and all IntegraMed Fertility Network patients immediately.
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 for the treatment of patients with castration resistant prostate cancer (CRPC). TOK-001 is the only compound in development that combines three distinct mechanisms of action for the treatment of CRPC.
› Verified 4 days ago
Michelle A Ludlow, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 808 Mill Lake Rd, Fort Wayne, IN 46845 Phone: 260-338-1241 Fax: 260-338-1231 | |
Linda Sue Sickman, PH.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1717 Maplecrest Rd, Fort Wayne, IN 46815 Phone: 260-493-0012 | |
Jennifer Lynn Garrett, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6329 Mapledowns Dr, Fort Wayne, IN 46835 Phone: 260-433-7903 | |
Jennifer Wilson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 808 Mill Lake Rd, Fort Wayne, IN 46845 Phone: 260-338-1241 Fax: 260-338-1231 | |
Mrs. Toni Walker Blackwood, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1923 Brandywine Trl, Fort Wayne, IN 46845 Phone: 260-637-3117 | |
Mrs. Kimberly A Griffith, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 6205 Constitution Dr, Fort Wayne, IN 46804 Phone: 260-438-3586 Fax: 877-992-0273 |